Some barbiturates enhance the effect of muscimol on dopamine turnover in the rat retina.
D000818:Animals; D001462:Barbital / Q000494:pharmacology; D001463:Barbiturates / Q000031:analogs & derivatives / Q000494:pharmacology*; D003292:Convulsants / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism*; D004357:Drug Synergism; D018756:GABA Antagonists; D008027:Light; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D009118:Muscimol / Q000494:pharmacology*; D010080:Oxazoles / Q000494:pharmacology*; D010424:Pentobarbital / Q000494:pharmacology; D010634:Phenobarbital / Q000494:pharmacology; D010852:Picrotoxin / Q000031:analogs & derivatives / Q000494:pharmacology; D051381:Rats; D012160:Retina / Q000187:drug effects* / Q000378:metabolism; D054830:Sesterterpenes; D005680:gamma-Aminobutyric Acid / Q000502:physiology
D001462:Barbital; D001463:Barbiturates; D003292:Convulsants; D004298:Dopamine; D018756:GABA Antagonists; D008781:Methyltyrosines; D009118:Muscimol; D010080:Oxazoles; D010424:Pentobarbital; D010634:Phenobarbital; D010852:Picrotoxin; D054830:Sesterterpenes; D005680:gamma-Aminobutyric Acid; C024321:5-(2-cyclohexylidene-ethyl)-5-ethylbarbiturate; C022961:picrotoxinin